Revolution Medicines, Inc. is 17.1x more valuable than Vericel Corp by market capitalization ($32.71 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | VCEL | RVMD |
|---|---|---|
| Market cap | $1.91 B | $32.71 B |
| US-listed rank | #2138 | #439 |
| Revenue (latest FY) | $276.26M | $0.00 |
| Net income (latest FY) | $16.52M | -$1.13B |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 115.8 | - |
| SEC filings | 1,674 | 782 |
Revolution Medicines, Inc. is 17.1x more valuable than Vericel Corp by market capitalization ($32.71 B vs $1.91 B).
In their latest fiscal years, Vericel Corp reported $276.26M in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: Vericel Corp and Revolution Medicines, Inc., or browse the full rankings.